您的当前位置:首页 > 行业数据 > Figure 2 R&D efficiency: R&D investment per approval by company type, including number of NME and NME + LCM approvals per $1B in R&D Approvals¹ per $1B of R&D, by company² scale (2015-2023) Number of approvals per $1B R&D spend

Figure 2 R&D efficiency: R&D investment per approval by company type, including number of NME and NME + LCM approvals per $1B in R&D Approvals¹ per $1B of R&D, by company² scale (2015-2023) Number of approvals per $1B R&D spend

图片属性
图片格式:PNG 图片大小:73KB 图片尺寸:1754*723
同报告图片
 / 4
Figure 2  
R&D efficiency: R&D investment per approval by company type, including number of NME and NME + LCM approvals per $1B in R&D  
Approvals¹ per $1B of R&D, by company² scale (2015-2023)  
Number of approvals per $1B R&D spend_第1页
0
Figure 2  
R&D efficiency: R&D investment per approval by company type, including number of NME and NME + LCM approvals per $1B in R&D  
Approvals¹ per $1B of R&D, by company² scale (2015-2023)  
Number of approvals per $1B R&D spend_第2页
Figure 2  
R&D efficiency: R&D investment per approval by company type, including number of NME and NME + LCM approvals per $1B in R&D  
Approvals¹ per $1B of R&D, by company² scale (2015-2023)  
Number of approvals per $1B R&D spend_第3页
Figure 2  
R&D efficiency: R&D investment per approval by company type, including number of NME and NME + LCM approvals per $1B in R&D  
Approvals¹ per $1B of R&D, by company² scale (2015-2023)  
Number of approvals per $1B R&D spend_第4页
Figure 2  
R&D efficiency: R&D investment per approval by company type, including number of NME and NME + LCM approvals per $1B in R&D  
Approvals¹ per $1B of R&D, by company² scale (2015-2023)  
Number of approvals per $1B R&D spend_第5页
所属报告: 艾意凯咨询:2026生物制药企业的制胜之道:L.E.K.洞察:创新、增长与核心竞争力研究报告(英文版)(117页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠